Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:27:11.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previous detailed study content. Access to the study details is blocked on this page.
    Difference
    18%
    Check dated 2026-09-23T00:45:40.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The bottom of the page shows Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a site version update rather than changes to trial details.
    Difference
    0.0%
    Check dated 2026-09-15T23:51:15.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's deployment without altering the study information.
    Difference
    0.0%
    Check dated 2026-09-01T19:45:00.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new funding line indicating the 2016 U.S. NIH grant/contract was added to the study record. This addition provides funding attribution within the study's details.
    Difference
    0.0%
    Check dated 2026-08-25T19:40:07.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now shown, replacing the previous v3.6.4, indicating a minor site update to the page template.
    Difference
    0.0%
    Check dated 2026-08-11T15:45:06.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.